deguelin has been researched along with Cancer of Colon in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, MY; Jung, HC; Kang, HW; Kim, JM; Kim, JS; Song, IS | 1 |
| Kosmeder, JW; Mehta, RG; Murillo, G; Pezzuto, JM; Salti, GI | 1 |
| Kosmeder, JW; Mehta, RG; Murillo, G; Pezzuto, JM | 1 |
3 other study(ies) available for deguelin and Cancer of Colon
| Article | Year |
|---|---|
Deguelin, an Akt inhibitor, down-regulates NF-κB signaling and induces apoptosis in colon cancer cells and inhibits tumor growth in mice.
Topics: Animals; Apoptosis; bcl-X Protein; Blotting, Western; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspase 3; Cell Line, Tumor; Colonic Neoplasms; Down-Regulation; In Situ Nick-End Labeling; Interleukin-8; Mice; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Real-Time Polymerase Chain Reaction; Rotenone; Signal Transduction; Statistics, Nonparametric | 2012 |
Deguelin inhibits the growth of colon cancer cells through the induction of apoptosis and cell cycle arrest.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Division; Colonic Neoplasms; Cyclin-Dependent Kinases; HT29 Cells; Humans; Microfilament Proteins; Muscle Proteins; Proliferating Cell Nuclear Antigen; Retinoblastoma Protein; Rotenone; Tumor Cells, Cultured; Up-Regulation | 2002 |
Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice.
Topics: Animals; Anticarcinogenic Agents; Azoxymethane; beta-N-Acetylhexosaminidases; Colon; Colonic Neoplasms; Female; Intestinal Mucosa; Mice; Molecular Structure; Piroxicam; Precancerous Conditions; Rotenone | 2003 |